DENVER, Colo., 28 October, 2024 (247marketnews.com) – (NASDAQ:GLUE) are discussed in this article. Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) is...
– ATEV™ demonstrated superiority at six and 12 months (co-primary endpoints) compared to autogenous fistula, the current standard of care...
SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company...
The Israel Innovation Authority will fund Pluri and BIRAD's collaboration to advance MAIT Cell Therapy, led by Professor Cyrille Cohen,...
BELMONT, N.C.--(BUSINESS WIRE)--Piedmont Lithium (“Piedmont” or the “Company”) (NASDAQ:PLL; ASX: PLL), a leading North American supplier of lithium products critical...
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024,...
Agreement expected to accelerate MRT-6160 clinical development and broadly explore therapeutic opportunities across multiple indications Monte Rosa to receive up-front...
VANCOUVER, British Columbia and ROAD TOWN, British Virgin Islands, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Bluestone Resources Inc. ("Bluestone") (TSXV:BSR...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the presentation of new sebetralstat data at the...
HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP) or “CenterPoint” today reported income available to common shareholders of $193 million, or $0.30...
HOUSTON--(BUSINESS WIRE)--Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the third quarter ended...
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2024) - Cabral Gold Inc. (TSXV: CBR) (OTC Pink: CBGZF) ("Cabral" or the "Company") is...
Progress on OCU400 Phase 3 liMeliGhT clinical trial for retinitis pigmentosa (RP) and new data from Phase 1/2Preliminary safety and efficacy...
DESIGNATED NEWS RELEASEVANCOUVER, BC, Oct. 28, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company")...
~ Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~ ~ Terry Evans Appointed Chief Commercial Officer ~ ~...
BOCA RATON, Fla., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced a...
TORONTO--(BUSINESS WIRE)--Largo Inc. ("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO) is pleased to report a significant increase in Mineral...
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to...
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2024) - Rua Gold Inc. (TSXV: RUA) (OTCQB: NZAUF) (WKN: A4010V) ("RUA GOLD"...
ArcelorMittal (‘the Company’) today announces the publication of its third quarter 2024 sell-side analyst consensus figures. The consensus figures are...
Order Volume increased 61% YoY to record high $4.92 millionGross Profit increased 61% YoY and reported Gross Margin increased to...
Additional senior leadership team hire underscores the company's commitment to improving emergency preparation, management and coordination after Hurricane Beryl HOUSTON,...
IDE275 (GSK959) development is progressing into First-in-Human Phase 1 clinical trial(s) for the treatment of MSI-High solid tumors, representing IDEAYA's...
Biomarker data suggest ALS patients may benefit from longer-term treatment with NurOwn Poster highlighting design of planned Phase 3b NurOwn...
HAIFA, Israel, Oct. 28, 2024 /PRNewswire/ -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today...
SAN ANTONIO, Oct. 28, 2024 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the "Company") today announced that a subsidiary...
Primary endpoint was met with 74% of participants dosed with LNZ100 achieving three-lines or greater improvement at 3 hours post...
Oral presentation highlights findings that patients treated with Lomecel-BTM in ELPIS I, in an open-label follow-on study, experienced 5-year survival...
FLORHAM PARK, N.J., Oct. 27, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company...
The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after...
Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to prevent kidney failure in patients...
Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS...
CALHOUN, Georgia, Oct. 26, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) heeft vandaag haar nettowinst van $ 162...
Singapore, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SIMPPLE LTD. (Nasdaq: SPPL) (the “Company” or “SIMPPLE”), an advanced technology solution provider...
SANDUSKY, Ohio, Oct. 25, 2024 /PRNewswire/ -- Civista Bancshares, Inc. (NASDAQ: CIVB) ("Civista") announced today that the Board of Directors...
Expert after-action report outlines 77 recommendations to improve storm response; CenterPoint has already completed or is implementing two-thirds of the...
NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (NASDAQ: NFE) (“NFE” or the “Company”) is pleased to announce that its initial Fast...
WASHINGTON, Pa.--(BUSINESS WIRE)--CB Financial Services, Inc. (“CB” or the “Company”) (NASDAQGM: CBFV), the holding company of Community Bank (the “Bank”),...
VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Versus Systems Inc. (NASDAQ: VS) (the “Company”) announces the appointment of...
